Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. Cardiac valve repair devices are used in the Open-Heart surgery to repair the malfunctioning of valves. GlobalData uses proprietary data and analytics to provide a comprehensive report on the cardiac valve repair devices devices market, including market shares of different players within Finland. Buy the latest report here.
In 2022, GlobalData’s Market Model methodology determined that the leading player in the cardiac valve repair devices market in Finland was Edwards Lifesciences followed by Medtronic, Abbott Laboratories and LivaNova.
Only mitral valve repair has been covered under this segment. Tricuspid and Aortic annuloplasty devices are not included here. Annuloplasty is a technique used to repair an enlarged annulus; either a ring or band is placed at the base of the heart valve. This annuloplasty device makes the opening of valve smaller and provides support to the valve so it can close more tightly. Mitral Valve Annuloplasty Devices consist of the annuloplasty rings and bands that are used in the repair of mitral valves.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the cardiac valve repair devices devices market within Finland was expected to be over $0.3m in 2022.
For the latest complete market share analysis of cardiac valve repair devices device market in Finland, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.